Skip to main content
Top
Published in: BMC Medical Informatics and Decision Making 1/2023

Open Access 01-12-2023 | Software

Development of an integrated and comprehensive clinical trial process management system

Authors: Liang Shen, You Zhai, AXiang Pan, Qingwei Zhao, Min Zhou, Jian Liu

Published in: BMC Medical Informatics and Decision Making | Issue 1/2023

Login to get access

Abstract

Background

The process of initiating and completing clinical drug trials in hospital settings is highly complex, with numerous institutional, technical, and record-keeping barriers. In this study, we independently developed an integrated clinical trial management system (CTMS) designed to comprehensively optimize the process management of clinical trials. The CTMS includes system development methods, efficient integration with external business systems, terminology, and standardization protocols, as well as data security and privacy protection.

Methods

The development process proceeded through four stages, including demand analysis and problem collection, system design, system development and testing, system trial operation, and training the whole hospital to operate the system. The integrated CTMS comprises three modules: project approval and review management, clinical trial operations management, and background management modules. These are divided into seven subsystems and 59 internal processes, realizing all the functions necessary to comprehensively perform the process management of clinical trials. Efficient data integration is realized through extract-transform-load, message queue, and remote procedure call services with external systems such as the hospital information system (HIS), laboratory information system (LIS), electronic medical record (EMR), and clinical data repository (CDR). Data security is ensured by adopting corresponding policies for data storage and data access. Privacy protection complies with laws and regulations and de-identifies sensitive patient information.

Results

The integrated CTMS was successfully developed in September 2015 and updated to version 4.2.5 in March 2021. During this period, 1388 study projects were accepted, 43,051 electronic data stored, and 12,144 subjects recruited in the First Affiliated Hospital, Zhejiang University School of Medicine.

Conclusion

The developed integrated CTMS realizes the data management of the entire clinical trials process, providing basic conditions for the efficient, high-quality, and standardized operation of clinical trials.
Literature
1.
go back to reference Kruizinga MD, Stuurman FE, Exadaktylos V, Doll RJ, Stephenson DT, Groeneveld GJ, et al. Development of novel, value-based, digital endpoints for clinical trials: a structured approach Toward fit-for-purpose validation. Pharmacol Rev. 2020;72:899–909.CrossRefPubMed Kruizinga MD, Stuurman FE, Exadaktylos V, Doll RJ, Stephenson DT, Groeneveld GJ, et al. Development of novel, value-based, digital endpoints for clinical trials: a structured approach Toward fit-for-purpose validation. Pharmacol Rev. 2020;72:899–909.CrossRefPubMed
2.
go back to reference Davi R, Mahendraratnam N, Chatterjee A, Dawson CJ, Sherman R. Informing single-arm clinical trials with external controls. Nat Rev Drug Discov. 2020;19:821–2.CrossRefPubMed Davi R, Mahendraratnam N, Chatterjee A, Dawson CJ, Sherman R. Informing single-arm clinical trials with external controls. Nat Rev Drug Discov. 2020;19:821–2.CrossRefPubMed
3.
go back to reference Desai A, Gainor JF, Hegde A, Schram AM, Curigliano G, Pal S, et al. Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials. Nat Rev Clin Oncol. 2021;18:320.CrossRefPubMedPubMedCentral Desai A, Gainor JF, Hegde A, Schram AM, Curigliano G, Pal S, et al. Author Correction: COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials. Nat Rev Clin Oncol. 2021;18:320.CrossRefPubMedPubMedCentral
4.
go back to reference Manem VSK, Salgado R, Aftimos P, Sotiriou C, Haibe-Kains B. Network science in clinical trials: a patient-centered approach. Semin Cancer Biol. 2018;52:135–50.CrossRefPubMed Manem VSK, Salgado R, Aftimos P, Sotiriou C, Haibe-Kains B. Network science in clinical trials: a patient-centered approach. Semin Cancer Biol. 2018;52:135–50.CrossRefPubMed
5.
go back to reference Tan EK. Movement disorders in 2020: clinical trials, genetic discoveries, and COVID-19. Lancet Neurol. 2021;20:10–2.CrossRefPubMed Tan EK. Movement disorders in 2020: clinical trials, genetic discoveries, and COVID-19. Lancet Neurol. 2021;20:10–2.CrossRefPubMed
6.
go back to reference Bhagat S, Kapatkar VK, Mane A, Pinto C, Parikh D, Mittal G, et al. An industry perspective on risks and mitigation strategies associated with post conduct phase of clinical trial. Rev Recent Clin Trials. 2020;15:28–33.CrossRefPubMed Bhagat S, Kapatkar VK, Mane A, Pinto C, Parikh D, Mittal G, et al. An industry perspective on risks and mitigation strategies associated with post conduct phase of clinical trial. Rev Recent Clin Trials. 2020;15:28–33.CrossRefPubMed
7.
go back to reference Nourani A, Ayatollahi H, Dodaran MS. A review of clinical data management systems used in clinical trials. Rev Recent Clin Trials. 2019;14(1):10–23.CrossRefPubMed Nourani A, Ayatollahi H, Dodaran MS. A review of clinical data management systems used in clinical trials. Rev Recent Clin Trials. 2019;14(1):10–23.CrossRefPubMed
8.
go back to reference Park YR, Yoon YJ, Koo HY, Yoo S, Choi CM, Beck SH, et al. Utilization of a clinical trial management system for the whole clinical trial process as an integrated database: system development. J Med Internet Res. 2018;20: e103.CrossRefPubMedPubMedCentral Park YR, Yoon YJ, Koo HY, Yoo S, Choi CM, Beck SH, et al. Utilization of a clinical trial management system for the whole clinical trial process as an integrated database: system development. J Med Internet Res. 2018;20: e103.CrossRefPubMedPubMedCentral
9.
go back to reference Nourani A, Ayatollahi H, Dodaran MS. Clinical trial data management software: a review of the technical features. Rev Recent Clin Trials. 2019;14(3):160–72.CrossRefPubMed Nourani A, Ayatollahi H, Dodaran MS. Clinical trial data management software: a review of the technical features. Rev Recent Clin Trials. 2019;14(3):160–72.CrossRefPubMed
10.
go back to reference Barlow C. Human subjects protection and federal regulations of clinical trials. Semin Oncol Nurs Apr. 2020;36(2):151001.CrossRef Barlow C. Human subjects protection and federal regulations of clinical trials. Semin Oncol Nurs Apr. 2020;36(2):151001.CrossRef
11.
go back to reference Barlow C. Oncology research: clinical trial management systems, electronic medical record, and artificial intelligence. Semin Oncol Nurs Apr. 2020;36(2):151005.CrossRef Barlow C. Oncology research: clinical trial management systems, electronic medical record, and artificial intelligence. Semin Oncol Nurs Apr. 2020;36(2):151005.CrossRef
13.
go back to reference Jørgensen L, Paludan-Müller AS, Laursen DR, Savović J, Boutron I, Sterne JA, et al. Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews. Syst Res May. 2016;10(5):80. Jørgensen L, Paludan-Müller AS, Laursen DR, Savović J, Boutron I, Sterne JA, et al. Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews. Syst Res May. 2016;10(5):80.
14.
go back to reference Cowie MR, Blomster JI, Curtis LH, Duclaux S, Ford I, Fritz F, et al. Electronic health records to facilitate clinical research. Clin Res Cardiol. 2017;106(1):1–9.CrossRefPubMed Cowie MR, Blomster JI, Curtis LH, Duclaux S, Ford I, Fritz F, et al. Electronic health records to facilitate clinical research. Clin Res Cardiol. 2017;106(1):1–9.CrossRefPubMed
15.
go back to reference Sharma A, Harrington RA, McClellan MB, Turakhia MP, Eapen ZJ, Steinhubl S, et al. Using digital health technology to better generate evidence and deliver evidence-based care. J Am Coll Cardiol. 2018;71(23):2680–90.CrossRefPubMed Sharma A, Harrington RA, McClellan MB, Turakhia MP, Eapen ZJ, Steinhubl S, et al. Using digital health technology to better generate evidence and deliver evidence-based care. J Am Coll Cardiol. 2018;71(23):2680–90.CrossRefPubMed
16.
go back to reference Kempf L, Goldsmith JC, Temple R. Challenges of developing and conducting clinical trials in rare disorders. Am J Med Genet AApr. 2018;176(4):773–83.CrossRef Kempf L, Goldsmith JC, Temple R. Challenges of developing and conducting clinical trials in rare disorders. Am J Med Genet AApr. 2018;176(4):773–83.CrossRef
17.
go back to reference Brasil S, Pascoal C, Francisco R, Dos Reis Ferreira V, Videira PA, Valadão AG. Artificial intelligence (AI) in rare diseases: Is the future brighter? Genes (Basel). 2019;10(12):978.CrossRefPubMedPubMedCentral Brasil S, Pascoal C, Francisco R, Dos Reis Ferreira V, Videira PA, Valadão AG. Artificial intelligence (AI) in rare diseases: Is the future brighter? Genes (Basel). 2019;10(12):978.CrossRefPubMedPubMedCentral
18.
go back to reference Wu J, Wang C, Toh S, Pisa FE, Bauer L. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions. Pharmacoepidemiol Drug Saf Oct. 2020;29(10):1213–8.CrossRef Wu J, Wang C, Toh S, Pisa FE, Bauer L. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions. Pharmacoepidemiol Drug Saf Oct. 2020;29(10):1213–8.CrossRef
19.
go back to reference Groft SC, Posada de la Paz M. Preparing for the future of rare diseases. Adv Exp Med Biol. 2017;1031:641–8.CrossRefPubMed Groft SC, Posada de la Paz M. Preparing for the future of rare diseases. Adv Exp Med Biol. 2017;1031:641–8.CrossRefPubMed
20.
go back to reference Hurley C, Shiely F, Power J, Clarke M, Eustace JA, Flanagan E, et al. Risk based monitoring (RBM) tools for clinical trials A systematic review. Contemp Clin Trials. 2016;51:15–27.CrossRefPubMed Hurley C, Shiely F, Power J, Clarke M, Eustace JA, Flanagan E, et al. Risk based monitoring (RBM) tools for clinical trials A systematic review. Contemp Clin Trials. 2016;51:15–27.CrossRefPubMed
Metadata
Title
Development of an integrated and comprehensive clinical trial process management system
Authors
Liang Shen
You Zhai
AXiang Pan
Qingwei Zhao
Min Zhou
Jian Liu
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Medical Informatics and Decision Making / Issue 1/2023
Electronic ISSN: 1472-6947
DOI
https://doi.org/10.1186/s12911-023-02158-8

Other articles of this Issue 1/2023

BMC Medical Informatics and Decision Making 1/2023 Go to the issue